HIV molecular immunology database

Search CTL/CD8+ T-Cell Epitope Database

HIV protein

HXB2 protein location

—

HXB2 DNA location

—

Results overlap with query location

Vaccine details
if Immunogen is Vaccine

Vaccine type
Vaccine strain
Vaccine component
Adjuvant

First Last

Click for Search Help

Search CTL/CD8+ variants

Questions or comments? Contact us at immuno@lanl.gov

- ALL -
Gag
p17
p24
p2p7p1p6
Gag/Pol
Pol
Gag/Pol-TF
Protease
RT
Integrase
Vif
Vpr
Tat
Rev
Vpu
gp160
Env
Nef
Cryptic
HIV-1
- NULL -
gp120
gp41

- ALL -
computer prediction
HIV-1 and HCV co-infection
HIV-1 exposed seronegative
HIV-1 infected monocyte-derived
HIV-1 infection
HIV-1 or HIV-2 infection
HIV-2 infection
in vitro stimulation or selection
peptide-HLA interaction
SHIV infection
SIV infection
vaccine
virus

- ALL -
A*01
A*0101
A*0123
A*02
A*0201
A*0202
A*0205
A*0206
A*0207
A*0214
A*0217
A*03
A*0301
A03 supertype
A*0801
A1
A11
A*11
A*1101
A*1103
A11.1
A19
A2
A2.1
A23
A*23
A*2301
A24
A*24
A*2402
A25
A*25
A*2501
A26
A*26
A*2601
A*2602
A*2603
A*2638
A*2705
A28
A28 supertype
A29
A*29
A*2902
A2 supertype
A3
A30
A*30
A*3001
A*3002
A31
A*31
A*3101
A32
A*32
A*3201
A33
A*33
A*3301
A*3303
A*34
A*3402
A*36
A3 supertype
A*4002
A*4301
A66
A*66
A68
A*68
A*6801
A*6802
A68 supertype
A*69
A74
A*74
A*7401
A*80
B*07
B*0702
B*0705
B*08
B*0801
B12
B13
B*13
B*1302
B14
B*14
B*1401
B*1402
B*1403
B15
B*15
B*1501
B*1502
B*1503
B*1510
B*1516
B*1517
B*1524
B*1540
B17
B18
B*18
B*1801
B27
B*27
B*2703
B*2705
B35
B*35
B*3501
B*3502
B*3503
B*3505
B*3508
B37
B*37
B*3701
B38
B*38
B*3801
B39
B*39
B*3901
B*3910
B40
B*40
B*4001
B*4002
B*4006
B*41
B42
B*42
B*4201
B*4202
B44
B*44
B*4402
B*4403
B*4415
B45
B*45
B*4501
B*4801
B49
B*49
B*4901
B5
B50
B*50
B*5001
B51
B*51
B*5101
B52
B*52
B*5201
B53
B*53
B*5301
B*54
B*5401
B55
B*55
B*5501
B56
B57
B*57
B*5701
B*5702
B*5703
B58
B*58
B*5801
B*5802
B60
B*60
B61
B*61
B62
B*62
B63
B*63
B*6701
B*68
B7
B70
B*70
B71
B*73
B*78
B7 supertype
B8
B81
B*81
B*8101
B*82
C*01
C*02
C*03
C*0304
C*04
C*05
C*06
C*07
C*08
C*12
C*14
C*15
C*16
C*17
C*18
Cw*01
Cw*0102
Cw*0202
Cw*03
Cw*0303
Cw*0304
Cw*04
Cw*0401
Cw*0407
Cw*05
Cw*0501
Cw*06
Cw*0602
Cw*07
Cw*0701
Cw*0702
CW*0702
Cw*0704
Cw*08
Cw*0801
Cw*0802
Cw*0804
Cw1
Cw12
Cw*12
Cw*1202
Cw*1203
Cw*14
Cw*1402
Cw15
Cw*15
Cw*1701
Cw18
Cw*18
Cw*1801
Cw2
Cw3
Cw4
Cw5
Cw6
Cw7
Cw8
DPw4.2
DR1
DR4
DRA
H-2d
H-2D
H-2Db
H-2Dd
H-2Dp
H-2Dq
H-2Kd
H-2Kk
H-2Ld
H-2a
H-2b
H-2bxd
H-2d17
H-2d
H-2f
H-2kd
H-2k
H-2p
H-2q
H-2u
Mamu A*01
Mamu-A*01
Mamu-A1*043:01
Mamu A1*065:01
Mamu-A*11
Mamu A*90120-5
Mamu-B*03
Mamu-B*04
Mamu B*08
Mamu B*17
Mamu-B*17
Mane A*10
Patr-B*02
Patr-B*03
Patr-B*14

- ALL -
acute/early infection
adjuvant comparison
antagonism
antibody binding site
antibody generation
assay development
autologous responses
binding affinity
bispecific molecule
broad neutralizer
CD4+ CTL
cell-line isolated antibody
characterizing CD8+ T cells
chronic infection
class I down-regulation by Nef
compensatory mutation
computational epitope prediction
co-receptor
cryptic epitope
dendritic cells
drug resistance
dynamics
early-expressed proteins
early treatment
elite controllers
enhancing activity
epitope processing
escape
genital and mucosal immunity
HAART, ART
HIV-2
HIV exposed persistently seronegative (HEPS)
HLA associated polymorphism
HLA cross-presentation
immunodominance
immunotherapy
junction or synthetic peptide
kinetics
memory cells
mimotopes
mother-to-infant transmission
mutation acquisition
neutralization by CTL
NK cells
non-susceptible form
novel epitope
optimal epitope
protective allele
rate of progression
responses in children
review
SIV
structure
subtype comparisons
superinfection
supertype
supervised treatment interruptions (STI)
T-cell crossreactivity to human proteins
TCR usage
Th1
Th2
therapeutic vaccine
vaccine antigen design
vaccine-induced immune responses
variant cross-reactivity
viral fitness and reversion